For researchers based in Bangkok, BPC-157 10mg is available with same-day collection
Molecular Profile Molecular Weight 403.93 Da (free) / 467.04 Da (Cu complex) Sequence GHK (Gly-His-Lys, 3 amino acids) Purity Spec 98% by HPLC Storage Store lyophilized at 20C

Contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndromes (MEN 2) Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis Should not be used alongside other GLP-1 receptor medications Gastric emptying may be delayed, requiring caution for procedures involving sedation or general anesthesia due to aspiration risk Use caution in those with a history of diabetic retinopathy 1-3 Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk Serious side effects may involve hypoglycemia, kidney issues, or allergic reactions Avoid use during pregnancy and breastfeeding 1 Enhances glucose-dependent insulin secretion Suppresses glucagon secretion Slows gastric emptying Influences brain regions involved in appetite regulation, leading to reduced hunger and caloric intake Improves insulin sensitivity 1-3 Supports weight loss Helps to minimize internal inflammation and improves cardiometabolic health measures 5 Q: How long does it take to see results

However, they are not a substitute for medications in severe or rapidly progressing cases
Injection sites should be rotated, and our guides on how to inject GLP-1 compounds and optimal injection locations cover the specific techniques
10.1073/pnas.1203567109 Proc